SCM
AEON icon

Shaolin Capital Management’s AEON Biopharma AEON Stock Holding History

Shaolin Capital Management’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-297
Closed -$248K – 350
2024
Q1 		$248K Buy
+297
New +$215K ﹤0.01% 115
2023
Q2 		– Sell
-1,389
Closed -$1.01M – 637
2023
Q1 		$1.01M Sell
1,389
-9,860
-88% -$7.15M 0.03% 304
2022
Q4 		$8.14M Hold
11,249
– – 0.24% 113
2022
Q3 		$7.98M Hold
11,249
– – 0.22% 134
2022
Q2 		$7.95M Hold
11,249
– – 0.19% 133
2022
Q1 		$7.92M Hold
11,249
– – 0.2% 122
2021
Q4 		$7.87M Hold
11,249
– – 0.2% 116
2021
Q3 		$7.89M Buy
+11,249
New +$7.86M 0.24% 100

Other funds holding AEON

ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Shaolin Capital Management's AEON Position: Q2 2024 in Review

Shaolin Capital Management sold out of AEON Biopharma (AEON) in Q2 2024, closing a stake of 297 shares — an estimated $248K sold.

Shaolin Capital Management first reported a position in AEON in Q3 2021 and held it in 8 quarters. The position peaked at $8.14M in Q4 2022. 24 funds tracked by Wall St. Rank hold AEON as of Q2 2024.

  • Shaolin Capital Management reported no remaining AEON Biopharma position as of Q2 2024 after selling out during the quarter.
  • Shaolin Capital Management sold 297 AEON Biopharma shares in Q2 2024, an estimated $248K.
  • Shaolin Capital Management first reported a position in AEON Biopharma in Q3 2021 and held it in 8 quarters.
  • Shaolin Capital Management's AEON Biopharma position peaked at $8.14M in Q4 2022.
  • 24 funds tracked by Wall St. Rank held AEON Biopharma as of Q2 2024.

Based on Shaolin Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.